期刊文献+

中药复方抑瘤饮对小鼠S180移植瘤血管生成的动态研究 被引量:6

Dynamic study on effect of Chinese medicine compound Yiliuyin on angiogenesis in transplanted S180 tumor of mouse
原文传递
导出
摘要 目的:研究荷S180瘤小鼠灌服中药复方抑瘤饮不同时间点肿瘤内血管生成的动态变化,揭示抑瘤饮体内抗瘤的作用机制。方法:56只BALB/c小鼠随机分为抑瘤饮组和对照组(n=28),每组分为4个亚组(每亚组7只)。右腋皮下接种S180肿瘤细胞24 h后,抑瘤饮组小鼠灌服抑瘤饮,对照组小鼠灌服等量凉开水,每日2次,每次0.5 mL;2组分别于灌服第10,20,30,40天点各处死一亚组小鼠。分离肿瘤制成石蜡包埋切片,免疫组化法检测肿瘤组织内血管生成(CD34染色)、血管内皮生长因子(VEGF)、血管内皮生长因子受体-2(VEGFR-2)和内皮抑素(ES)的动态变化,结果以阳性酶点(positive enzyme dot,PED)表示。结果:抑瘤饮能显著降低肿瘤组织内微血管生成:抑瘤饮组CD34在第10,20,30,40天点PED均低于对照组(分别P<0.05,P<0.01,P<0.01和P<0.01)。抑制VEGF和VEGFR-2的表达:抑瘤饮组VEGF在第10,20,30,40天点PED均低于对照组(分别P<0.05,P<0.01,P<0.01和P<0.01):抑瘤饮组VEGFR-2在相应时间点均低于对照组(分别P<0.05,P<0.01,P<0.01,P<0.01)。促进ES的表达:抑瘤饮组ES在相应时间点与对照组比第10天点PED无明显差异,在第20,30,40天点PED均高于对照组(分别P<0.05,P<0.05和P<0.01)。结论:抑瘤饮体内可通过下调VEGF和VEGFR-2表达,上调ES表达,抑制肿瘤组织内血管生成发挥抗瘤作用。 Objective:To investigate the dynamic changes in angiogenesis within the tumor tissue of mice bearing S180 tumor at different day-points of oral administration with a Chinese medicine compound"Yiliuyin"(YLY) and to explore the anti-tumor mechanisms of YLY in vivo.Method:Fifty-six BALB/c mice were divided into YLY group and control group (28 mice/group) and each group was divided into four subgroups (7 mice/subgroup),randomly.After 24 hrs of inoculation with S180 tumor cells subcutaneously in the right axilla...
出处 《中国中药杂志》 CAS CSCD 北大核心 2009年第2期212-216,共5页 China Journal of Chinese Materia Medica
基金 河北省中医药管理局基金项目(2006054)
关键词 抑瘤饮 肿瘤血管生成 CD34 血管内皮生长因子 血管内皮生长因子受体-2 内皮抑素 Yiliuyin tumor angiogenesis CD34 VEGF VEGFR-2 endostatin
  • 相关文献

参考文献8

二级参考文献53

  • 1熊正文,李春光,丁华野,史景泉.肿瘤组织微血管生成及微循环形态学研究技术[J].中国组织化学与细胞化学杂志,1998,7(4):139-140. 被引量:6
  • 2孙太振,郑玉玲,王祥麒.芪瑞扶正胶囊对肺癌IL-2NK细胞活性和T细胞亚群的影响[J].中医药学刊,2004,22(12):2229-2230. 被引量:4
  • 3Aboudkhil S, Zaid A, Henry L, et al. Influence of age,castration, and testosterone on T cell subsets in heahhy and leukemia grafted mice [J]. J Biol Cell, 2003,95( 1 ) : 9-16.
  • 4Wang S, Zheng Z, Weng Y, et al. Angiogenesis and antiangiogenesis activity of Chinese medicinal herbal extracts[J]. Life Sci, 2004,74(20):2467-2478.
  • 5Su SJ, Yeh TM, Chuang WJ, et al, The novel targets for anti-angiogenesis of genistein on human cancer cells [J]. Biochem Pharmacol, 2005,69(2) :307-318.
  • 6Hsu YL, Kuo PL, Lin CC, et al. The proliferative inhibition and apoptotic mechanism of Saikosaponin D in human non-small cell lung cancer A549 cells [J]. Life Sci, 2004,75(10):1231-1242.
  • 7Cheng YL, Chang WL, Lee SC, et al. Acetone extract of Angelica sinensis inhibits proliferation of human cancer cells via inducing cell cycle arrest and apoptosis [J]. Life Sci,2004,75(13) :1579-1594.
  • 8[1]Peper MS, Wasiw, Feriara AN, et al. In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells[J]. Exp Cell Res, 1994, 210(2): 2998-230.
  • 9[2]Maehara Y, Kabashima A, Koga T, et al. Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma[J]. Surgery,2000, 128(3):408-416.
  • 10[3]Yonemura Y, Fushida S, Bando E,et al. Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer[J]. European journal of cancer (Oxford, England:1990), 2001, 37(7):918-923.

共引文献39

同被引文献142

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部